Syneos Health rises on beating Q4 earnings estimates
** Syneos Health's shares SYNH.O up 8.03% at $38.80 - the
biggest one-day pct. gain in three months
** Biopharmaceutical co reports Q4 revenue of $1.36 bln,
higher than analysts' avg. estimate of $1.29 bln - Refinitiv
IBES data urn:newsml:reuters.com:*:nGNX2XVY5C
** Q4 adj. profit was $1.23/share, beating estimates of
$1.20/share - Refinitiv IBES data
** SYNH was down ~64% last year
(Reporting by Khushi Mandowara in Bengaluru)
((Khushi.Mandowara@thomsonreuters.com;))
Recent news on Syneos Health
See all newsHayward Holdings rises on S&P Smallcap 600 inclusion
Brief: Syneos Health And Oracle To Expand Partnership
Large LBO bond sales could prompt September US junk debt rush
Brief: SYNEOS HEALTH AND STAR PARENT ANNOUNCE PROPOSED $1.70 BILLION OFFERING OF SENIOR SECURED NOTES
Brief: Syneos Health Announces Agreement With Aotearoa Clinical Trials, Expanding Clinical Trial Capabilities Across Range Of Therapeutic Areas In New Zealand